Clinical Trials Browser

Phase 2 × Carcinoma, Neuroendocrine × PE regimen × Clear all

NCT03168594 2020-01-22

Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma

Phase 2 Terminated

Carcinoma, Neuroendocrine